Preeclampsia and Angiogenic Imbalance
- 1 February 2008
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 59 (1), 61-78
- https://doi.org/10.1146/annurev.med.59.110106.214058
Abstract
Preeclampsia is a systemic syndrome of pregnancy that originates in the placenta and is characterized by widespread maternal endothelial dysfunction. Until recently, the molecular pathogenesis of preeclampsia was largely unknown, but recent work suggests a key role for altered expression of placental antiangiogenic factors. Soluble Flt1 and soluble endoglin, secreted by the placenta, are increased in the maternal circulation weeks before the onset of preeclampsia. These antiangiogenic factors produce systemic endothelial dysfunction, resulting in hypertension, proteinuria, and the other systemic manifestations of preeclampsia. The molecular basis for placental dysregulation of these pathogenic factors remains unknown, and the role of angiogenic proteins in early placental vascular development is just beginning to be explored. These discoveries have exciting clinical implications and are likely to transform the detection and treatment of preeclampsia in the future.Keywords
This publication has 96 references indexed in Scilit:
- Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomesAmerican Journal of Obstetrics and Gynecology, 2007
- Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factorAmerican Journal of Obstetrics and Gynecology, 2007
- Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational HypertensionHypertension, 2005
- Hypertension During PregnancyHypertension, 2005
- PreeclampsiaHypertension, 2005
- Circulating Angiogenic Factors in the Pathogenesis and Prediction of PreeclampsiaHypertension, 2005
- Changes in Endothelial Function Precede the Clinical Disease in Women in Whom Preeclampsia DevelopsHypertension, 2005
- Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia developAmerican Journal of Obstetrics and Gynecology, 2004
- Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3JCI Insight, 2000
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences of the United States of America, 1993